This patent application is related to Italian Patent Applications No. 102021000027662 and No. 102021000027668 filed on Oct. 28, 2021, the entire disclosure of which is incorporated herein by reference.
The present invention relates to a system and method for a rapid and sterile transfer of a vial into an isolator, specifically an isolator for pharmaceutical use.
In particular, the present invention may be advantageously, but not exclusively applied in the step of transferring vials or containers for cryogenic storage of biological material (cryovials) from an outer environment to a working chamber of a pharmaceutical isolator, to which the following description will make explicit reference without losing its generality.
It is known to insert a cryovial into a pharmaceutical isolator by a procedure that requires several manual steps by an operator. Specifically, the operator must first decontaminate the cryovial under a laminar flow hood manually using a decontaminating agent, such as an alcohol-based solution, and then insert the cryovial into the isolator through a suitable small opening, commonly known as a mouse-hole, in a wall or hatch of the isolator.
Therefore, the aforesaid procedure for inserting a cryovial into an isolator is not repeatable, in that the level of decontamination of the cryovial is strongly affected by the behaviour of the operator. Moreover, the procedure, being time-consuming, is relatively slow.
The aim of the present invention is to realise a system for transferring a cryovial into an isolator and to provide a corresponding method for transferring a cryovial into an isolator that are capable of overcoming the drawbacks described above and, at the same time, are easy and cost-effective to manufacture.
In accordance with the present invention, they are provided a system for the rapid and sterile transfer of a vial into an isolator, in particular an isolator for pharmaceutical use, and a method for the rapid and sterile transfer of a vial into an isolator, according to what defined in the appended claims.
The present invention will now be described with reference to the accompanying drawings, which show a non-limiting embodiment thereof, wherein:
In
The transfer system 1 comprises a first chamber 6 having a first opening 7 provided with a first hatch 8 for inserting the vial 2 into the first chamber 6, a second chamber 9 communicating with the first chamber 6 through a second opening 10 and having a third opening 11 provided with a second hatch 12 for the exit of the vial 2, and a support structure 13, which encloses the two chambers 6 and 9 and that is mountable at a mounting opening 14 of the wall 4 in such a way that the opening 7 faces the outer environment 5 and the opening 11 faces the working chamber 3. Advantageously, the hatch 12 is motorised.
The transfer system 1 comprises a first transfer component 15, which is arranged in chamber 6, and a second transfer component 16, which is arranged in chamber 9. The transfer components 15 and 16 have respective shapes, shown in a simplified manner in
The transfer system 1 further comprises a ventilation apparatus 17, which is connected to the chamber 6 to circulate in the latter an air flow satisfying a certain class of particle content, and a sterilisation apparatus 18, which is connected to the chamber 9 to circulate in the latter a gaseous sterilising fluid, preferably vaporised hydrogen peroxide. The particle content class is, for example, class B according to EC GMP Guide, Annex 1.
Still referring to
In particular, the input branch 20 includes an input 25 that may be connected to a compressed air source (not shown). The modulating valve 23 is connected between the inlet 25 and the filter 22. The filter 22 has a pore size of less than 0.3 μm, in particular equal to 0.22 μm, to retain particles larger than the pores. Thereby, the inlet branch 20 is able to feed filtered compressed air with a variable flow rate into the chamber 6.
The pneumatic circuit 19 comprises an air extraction device 26, e.g. consisting of a Venturi ejector, connected at the end of the outlet branch 21 to draw air out of the chamber 6. The air extraction device 26 has an inlet 26a for a drawn fluid that is connected to the outlet branch 21 and an inlet 26b for a motor fluid. The inlet 26b may be connected to a compressed air source (not shown). The pneumatic circuit 19 comprises an on/off valve 27 connected to the inlet 26b to control the supply of compressed air to the air extraction device 26. The modulating valve 24, on the other hand, allows to adjust the flow rate of the air drawn from the chamber 6.
The pneumatic circuit 19 comprises an additional outlet branch 28, which consists in a duct connecting the chamber 9 with the air extraction device 26. The outlet branch 28 has an additional modulating valve 29 to adjust the flow rate of the air drawn from the chamber 9. The aim of the outlet branch 28 is to adjust the pressure inside the chamber 9, as will be further explained hereinafter.
The sterilisation apparatus 18 comprises a reservoir 30 to contain liquid hydrogen peroxide, a vaporizer 31 to vaporise hydrogen peroxide, a first pump 32 to feed the liquid hydrogen peroxide to the vaporizer 31, a pneumatic circuit 33 having a second pump 34 and connected to the chamber 9 to circulate the vaporised hydrogen peroxide in the latter.
In particular, the vaporizer 31 comprises a chamber 35 connected to the pneumatic circuit 33, a heater 36, in particular an electric heater, e.g. in the form of a plate, arranged in the chamber 35, and a needle 37, which protrudes into the chamber 35 above the heater 36 and is fed by the 15 pump 32 to drip the liquid hydroxide peroxide onto the heater 36.
The pump 32 has an inlet connected to a duct 38 which picks up from the tank 30. Advantageously, the pump 32 is a peristaltic pump. The reservoir 30 has a filter 39 to draw 20 in filtered air as a result of liquid hydrogen peroxide extraction. The filter 39 is a high efficiency filter, e.g. a HEPA filter. In particular, the filter 39 has a pore size of less than 0.3 μm, specifically equal to 0.22 μm.
The pneumatic circuit 33 comprises a bypass branch 40 connected in parallel to the vaporizer 31 via a pair of three-way valves 41 so that the vaporizer 31 can be excluded from an air circulation path flowing through the chamber 9. The bypass branch 40 comprises a filter 42 to allow removing the particulate matter during a step of aerating the chamber 9. The filter 42 is a high efficiency filter, e.g. a HEPA filter. In particular, the filter 42 has a pore size of less than 0.3 μm, in particular equal to 0.22 μm.
The pump 34 is connected between the chamber 9 and one of the two three-way valves 41 so as to be able to generate both the circulation of sterilising fluid, while transferring a vial 2 from the outer environment 5 to the working chamber 3 of the isolator, and the circulation of air, during the aforementioned step of aerating the chamber 9. Advantageously, the pump 34 is a diaphragm pump.
The transfer system 1 comprises a plurality of electrical heating elements 43 arranged in the support structure 13 to heat the chamber 9 in order to prevent condensation of the liquid hydrogen peroxide in the chamber 9 and thus transfer a dry vial 2 into the isolator.
The transfer system 1 comprises a plurality of sensors and a control unit 44 configured to control various motorised or electro-actuated components, in particular the hatch 12, the transfer components 15 and 16, the pumps 32 and 34, the modulating valves 23, 24, 27, 29 the three-way valves 41, the vaporizer 31 and the electrical heating elements 43, depending on one or more of the signals provided by the aforementioned sensors and on the basis of a sequence of steps involving the conditioning of the chambers 6 and 9 and the transfer of the vial 2 into the isolator.
In particular, the transfer system 1 comprises a temperature sensor 45 to measure the temperature in the chamber 9 and a humidity sensor 46 to measure the relative humidity in the chamber 9. The control unit 44 is configured to control the electrical heating elements 43 according to the signals provided by the temperature sensor 45 and humidity sensor 46 in such a way as to prevent condensation of the sterilising fluid in the chamber 9.
The transfer system 1 includes a pressure sensor 47 to measure the pressure in the chamber 9. The control unit 44 is configured to control the modulating valve 29 according to the signal provided by the pressure sensor 47 in order to maintain a constant pressure in the chamber 9. Indeed, the heating of the chamber 9 would cause, in the absence of the outlet branch 28, temporary increases in pressure within the chamber 9 during certain steps of the transfer process of the vial 2 during which the chamber 9 remains closed. The constant pressure, combined with temperature and relative humidity control, helps prevent condensation of the sterilising fluid.
The air extraction device 26 has its own outlet 26c connected to a neutralising device 48 adapted to neutralise the sterilising fluid arriving from the outlet 26c. The sterilising fluid arriving from the outlet 26c of the air extraction device 26 comes from the chamber 9 while the pressure therein is adjusted and, in small amounts, also from the chamber 6 through the opening 10 due to the transfer of the vial 2 from the chamber 6 to the chamber 9. In case the sterilising fluid is vaporised hydrogen peroxide, the neutralising device 48 comprises a catalyst to decompose the hydrogen peroxide into water.
According to alternative embodiments, the neutralising device 48 is either a part of the transfer system 1 or external to it.
The transfer system 1 comprises a sterilising fluid concentration sensor 49 to measure the concentration of the sterilising fluid in the chamber 9. Preferably, the sterilising fluid concentration sensor is arranged in the chamber 9. The control unit 44 is configured to control the pump 32 in such a way as to adjust the injection of liquid hydrogen peroxide into the vaporizer 31 at a desired value in terms of ml/min.
In the example shown in
Referring to
Hatch 8 and hatch 12 are normally closed. In
The transfer component 15 is in the form of a rotational solid defined by rotation about an axis 51, perpendicular to the plane of the view of
Advantageously, the transfer component 15 is in the form of a drum defined around the axis 51. In particular, the rotational solid defining the shape of the transfer component 15 is a sphere lacking two opposite spherical segments coaxial to the axis 51, as shown in
Advantageously, the transfer component 15 is made in a single piece.
The openings 7 and 10 are oriented according to respective axes (not shown) that are coaxial to axis 53. Preferably, the openings 7 and 10 are aligned with each other, i.e. their axes coincide.
The transfer system 1 comprises an annular hermetic sealing element 55, which is arranged around the opening 10 and has a cross-section shaped in such a way as to always remain in contact with a lateral outer surface 56 (
The chamber 6 comprises an inlet 6a and an outlet 6b (
The transfer component 15 comprises an additional hole 58 transverse to the axis 53 and communicating with the hole 52. In particular, the hole 58 connects a bottom portion of the volume of the hole 52 with the air gap 57 to allow circulation of the air flow in the hole 52 and thus ease maintaining the class of particle content also in the hole 52 and remove any residual sterilising fluid from the hole 52 before opening the hatch 8 for a subsequent transfer cycle of another vial 2.
The transfer component 16 consists of a basket, which is shaped to accommodate the vial 2 oriented according to an axis 59, and is motorised to rotate about an axis 60 perpendicular to the plane of the view of
Advantageously, the transfer component 16 is made in a single piece.
The opening 11 has a guide 61 which protrudes outside the chamber 9, and thus, in use, inside the working chamber 3 of the isolator, to bring and hold the vial 2 in a pick-up position which is easily accessible by the gloves worn by an operator and by an automatic pick-up system arranged in the working chamber 3.
The support structure 13 is advantageously subdivided into a first support body 62 and a second support body 63, at least one of which is fixable to the wall 4 of the isolator, about the mounting opening 14, and which are hermetically fixed to each other with the interposition of an O-ring 64, through the mounting opening 14 so that, in use, the support body 62 is arranged in the outer environment 5 and the support body 63 is arranged in the working chamber 3 of the isolator.
In the example of
The transfer system 1 may be employed to perform a method for a rapid and sterile transfer of a vial into an isolator, such a method comprising a plurality of steps described below referring in particular to the block diagram in
As already mentioned, the transfer system 1 is capable of transferring one vial 2 at a time into the working chamber 3 of the isolator. Normally, during a day of use of the isolator, a certain number of vials are transferred into the isolator.
Before transferring the vials, a step of pre-conditioning the chambers 6 and 9 is performed, in order to clean the air in the chambers 6 and 9, i.e. to achieve a certain class of particle content, and it is thus performed with the vaporizer 31 switched off.
The pre-conditioning step involves generating an air flow in the chamber 6 satisfying said class of particle content, by the pneumatic circuit 19, while the opening 7 is closed by the hatch 8 and the opening 10 is closed by the transfer component 15 in the first position (
The pre-conditioning step also involves generating a circulation of air in the chamber 9 by the pump 34 of the pneumatic circuit 33 to achieve, in chamber 9 as well, said class of particle content. For this purpose, the three-way valves 41 are switched to exclude the vaporizer 31 from the air circulation and thus make air circulate through the bypass branch 40 and the modulating valve 29 is shut.
The air flow into the chamber 6, generated by feeding compressed air into the chamber 6 through the inlet branch 20 of the pneumatic circuit 19 and drawing air from the chamber 6 through the outlet branch 21 of the pneumatic circuit 19, is no longer interrupted in the subsequent steps of the method for transferring the vial 2. In other words, the modulating valves 23 and 24 of the pneumatic circuit 19 and the valve 27 associated with the air extraction device 26 remain open at all times.
After the pre-conditioning step, the conditioning of the chamber 9 is activated by circulating sterilising fluid. Specifically, the vaporizer 31 is activated to generate the sterilising fluid and the three-way valves 41 are switched to exclude the bypass branch 40 in order to maintain a circulation of sterilising fluid in the chamber 9 through the pneumatic circuit 33. The electrical heating elements 43 are switched on and controlled according to the temperature and relative humidity measured by the temperature sensor 45 and humidity sensor 46 to prevent condensation of the sterilising fluid. The modulating valve 29 is opened and adjusted according to the pressure measured by the pressure sensor 47 in order to maintain conditions in the chamber 9 suitable for preventing condensation of the sterilising fluid.
At this point, the transfer system 1 is ready to receive the vial 2 as shown in
As a response to a command provided by the operator or generated by closing the hatch 8 by means of a button (not shown), preferably integrated in the support body 62, the transfer component 15 rotates about the axis 51 until it reaches the second position, thereby releasing the passage through the opening 10 (
The transfer component 15 temporarily remains in the second position, in particular for a time interval that is predetermined by the time taken by the vial 2 to reach the chamber 9, after which the transfer component 15 returns to the first position (
As mentioned above, the air flow in the chamber 6 is not interrupted. Thereby, the sterility conditions in the chamber 9 are substantially preserved and any residual sterilising fluid that might pass from the chamber 9 to the chamber 6 through the opening 10 during the transfer of vial 2 in the opposite direction would be drawn out of outlet branch 21 before opening the hatch 8 for a subsequent transfer cycle of another vial 2. The hole 58 facilitates the removal of sterilising fluid residues in the hole 52.
The vial 2 remains in the chamber 9 with the opening 10 closed by the transfer component 15 and the opening 11 closed by the hatch 12 for a predetermined time interval in order to allow the outer surface of the vial 2 to be sterilised. In this step, the transfer component 16 is moved one or more times between two positions such that the contact points between the vial 2 and the transfer component 16 vary to facilitate sterilisation of the entire outer surface of the vial 2. In particular, referring to
When the sterilisation step of the vial 2 is complete, the hatch 12 opens and the transfer component 16 rotates to the fourth position (
The air drawn from the chamber 9 through the outlet branch 28 of the pneumatic circuit 19 prevents any small amounts of sterilising fluid from leaving the chamber 9 and entering the working chamber 3.
At this point, the transfer component 16 is returned to the third position and the hatch 12 is closed (
Advantageously, the generation of the air flow into the chamber 6 occurs by adjusting the modulating valves 23 and 24 in such a way that the flow rate of the air drawn from the chamber 6 differs from the flow rate of the filtered compressed air fed into the chamber 6 as the steps of the transfer cycle of the vial 2 change.
For example, when the transfer component 15 is in the first position (
The method for the rapid and sterile transfer of a vial 2 also involves a step of globally aerating the transfer system 1 while keeping the vaporizer 31 switched off, i.e. of the two chambers 6 and 9 and of chamber 35 of the vaporizer 31, which may be performed, for example, at the end of a day of use of the isolator.
The step of globally aerating also involves circulating, in addition to the usual air flow into the chamber 6 through the inlet branch 20 and outlet branch 21 with the hatch 8 closed and opening 10 closed, an additional air flow into the chambers 9 and 35 through the pneumatic circuit 33 and outlet branch 28 with the hatch 12 open. Thus, the modulating valves 23, 24 and 29 are open and the three-way valves 41 are switched so as to exclude the bypass branch 40. Thereby, the class of particle content in the chamber 6 is maintained while any residual sterilising fluid is removed from the chambers 9 and 35 and is expelled from the air extractor device 26.
According to a further embodiment not shown, the transfer system 1 differs from the one shown in the Figures and described above in that it comprises, instead of the chambers 6 and 9 and the rotating-type transfer components 15 and 16, two chambers extending according to two respective directions parallel to each other, and two transfer components of the translating type, each of which is in the form of a cylinder without bases extending along its own longitudinal axis, is arranged in a respective chamber with its longitudinal axis perpendicular to the direction of the chamber and is adapted to translate into the chamber along that direction. Thus, a first one of the two transfer components translates in a first one of the two chambers between a first position, in which it is aligned to a first opening of the first chamber to receive the vial, and a second position, in which it is aligned to a second opening that connects the two chambers to transfer the vial into the second chamber; the second one of the two transfer components translates into the second one of the two chambers between a third position, in which it is aligned with a second opening to receive the vial, and a fourth position, in which it is aligned with a third opening of the second chamber to transfer the vial into the working chamber.
Although the above-described invention specifically refers to a very specific embodiment, it is not to be intended as limited to that embodiment, being included in its scope all those variations, modifications or simplifications as covered by the appended claims, such as, for example:
The main advantage of the above-described transfer system 1 and of the method for the rapid and sterile manner transfer of a vial into an isolator is that it allows the rapid insertion of a vial 2 into a working chamber 3 of an isolator without having to follow a manual procedure for decontaminating the vial 2. More specific advantages result clearly from the particular characteristics of the transfer system 1 and the particular steps of the method as described above. For example, the chambers 6 and 9 communicating only through the opening 10, the transfer components 15 and 16 movable inside the respective chambers 6 and 9 and the ventilation apparatus 17 connected to the chamber 6 make it possible to isolate the chamber 9, in which the sterilisation of the vial 2 takes place, from the outer environment 5 and at the same time from the working chamber 3 of the isolator. Another advantage is that the vial 2 transferred into the chamber 3 retains the same position as when it is Loaded into the chamber 6.
Number | Date | Country | Kind |
---|---|---|---|
102021000027662 | Oct 2021 | IT | national |
102021000027668 | Oct 2021 | IT | national |
Filing Document | Filing Date | Country | Kind |
---|---|---|---|
PCT/IB2022/060373 | 10/28/2022 | WO |